[Role of percutaneous coronary intervention in diabetic patients]

B Gencer1, S Noble, R F Bonvini

  • 1Service de cardiologie, Département des spécialités de médecine, HUG, 1211 Genève 14. baris.gencer@hcuge.ch

Revue Medicale Suisse
|June 25, 2013
PubMed

Insights

Diabetic patients have worse outcomes after coronary revascularization (surgery or PCI). For stable patients, surgery is preferred for multivessel disease, especially in diabetics, with a lower threshold for surgical intervention compared to percutaneous coronary intervention.

Area of Science:

  • Cardiology
  • Diabetology
  • Vascular Surgery

Background:

  • Diabetic patients experience poorer clinical outcomes following coronary revascularization procedures, including both surgical revascularization and percutaneous coronary intervention (PCI).
  • The choice of revascularization strategy (surgical, PCI, or conservative) in stable coronary artery disease (CAD) patients hinges on clinical factors like coronary anatomy and comorbidities.
  • Acute coronary syndrome (ACS) management often favors PCI due to elevated surgical risks during active infarction.

Purpose of the Study:

  • To analyze and compare clinical outcomes of surgical versus PCI revascularization in diabetic and non-diabetic patients.
  • To delineate the optimal revascularization strategy based on patient-specific factors, particularly in the context of diabetes mellitus.
  • To establish guidance on the decision-making threshold for surgical intervention versus PCI in stable CAD patients, with a focus on diabetic populations.

Main Methods:

  • Review of clinical outcomes data comparing surgical revascularization and percutaneous coronary intervention (PCI) in diabetic and non-diabetic patient cohorts.
  • Analysis of factors influencing revascularization modality selection, including coronary anatomy, comorbidities, and acute versus stable coronary syndromes.
  • Comparative assessment of risk stratification and clinical outcomes based on chosen treatment strategy.

Main Results:

  • Diabetic patients demonstrate significantly worse clinical outcomes after both surgical and PCI revascularization compared to non-diabetic individuals.
  • In stable coronary artery disease, factors such as multivessel disease and acceptable surgical risk favor surgical revascularization.
  • The threshold for recommending surgery over PCI is demonstrably lower in diabetic patients than in their non-diabetic counterparts.

Conclusions:

  • Diabetic patients represent a high-risk population for coronary revascularization, necessitating careful treatment strategy selection.
  • Surgical revascularization should be strongly considered for diabetic patients with multivessel coronary disease and suitable surgical profiles.
  • Clinical decision-making for revascularization in stable CAD must be individualized, with a lower threshold for surgical intervention in diabetic patients to optimize outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...